Key Highlights

● GrowGeneration shares jumped 26% as the company posted its third straight quarter of sales growth.

● The Denver-based hydroponics and cannabis-cultivation Supply retailer has been a cautionary tale, with its stock down more than 96% over five years.

● GrowGeneration repurchased 724,927 shares during the quarter at an average price of $1.38 under its $10 million buyback authorization.

● CEO Darren Lampert bought 64,098 shares on the open market in the roughly 90 days preceding the Earnings release, an insider confidence signal.

GrowGeneration Corp., the Denver-based hydroponics and cannabis-cultivation supply retailer, has spent much of the past several years as a cautionary tale of the cannabis-boom bust, its stock down more than 96% over five years and languishing near $1 for stretches of 2026. But the latest chapter complicates the "shares keep falling" narrative: after reporting second-quarter results on August 11, GRWG stock jumped roughly 26% the following trading session, closing near $1.88, as investors responded to a third consecutive quarter of year-over-year Revenue growth and the company's first positive adjusted EBITDA quarter in some time. The move underscores how small-cap, low-priced cannabis-adjacent names can swing sharply on modest fundamental shifts, and how a multi-year decline doesn't preclude a single-day reversal.

Latest Development

GrowGeneration reported second-quarter 2026 results after markets closed on August 11, according to a press release distributed via GlobeNewswire and the company's Investor relations site. Net sales came in at $43.2 million, up 5.5% year-over-year from $41.0 million and up roughly 12.6% sequentially, the third straight quarter of year-over-year growth, which management attributed to strength in its commercial B2B cultivation business. The net loss narrowed to $2.0 million ($0.03 per share) from $4.8 million a year earlier, beating consensus estimates that had called for a wider loss, per Investing.com's earnings recap. Adjusted EBITDA turned positive at $0.3 million, versus a $1.3 million loss in the prior-year quarter.

Management also disclosed that GrowGeneration repurchased 724,927 shares during the quarter at an average price of $1.38 under its $10 million buyback authorization, of which roughly $9 million remains available, a signal the company views its own depressed shares as undervalued. The company's 10-Q also noted an insider purchase: CEO Darren Lampert bought 64,098 shares on the open market in the roughly 90 days preceding the earnings release.

What the Numbers Show

Gross Margin held essentially flat at 28.5%, up slightly from 28.3% a year earlier. Six-month revenue reached $81.6 million versus $76.7 million in the same period of 2025, while the six-month net loss narrowed to $6.9 million from $14.2 million. Store and operating expenses fell 21.9% year-over-year to $6.1 million, and total operating expenses dropped 13.1% to $14.7 million, reflecting an ongoing cost-reduction push.

Proprietary-brand penetration, products sold under GrowGeneration's own labels such as Char Coir, Drip Hydro, Power Si and Ion lights, continued climbing, landing in the high-30s percentage range of cultivation-and-gardening revenue (company materials cited figures between roughly 38% and nearly 40%, up from 32.0% a year earlier), putting the company on pace to hit its stated year-end target of approximately 40%. Management said about 90% of proprietary-brand sales currently flow through its own commercial division rather than third-party retailers.

On the balance sheet, GrowGeneration held $41.0 million in cash, cash equivalents and marketable securities at quarter-end, with zero Debt and Working Capital of $74.0 million. Inventory stood at $35.3 million against current liabilities of $25.6 million. The retail footprint has continued to shrink: the company now operates 19 stores across nine states (about 492,000 square feet), after closing four locations during the first half of 2026 as part of a stated network-optimization strategy that has shifted emphasis toward commercial/wholesale distribution over physical retail. Management also flagged roughly $2–2.6 million in expected Tariff refunds tied to prior IEEPA duties, to be recognized in the third quarter.

For guidance, GrowGeneration reaffirmed full-year 2026 revenue of $162–168 million and gross margin of 27–29%, while raising full-year adjusted EBITDA guidance to $2–3 million from a prior breakeven target. Third-quarter revenue is expected in a $44–46 million range with continued positive adjusted EBITDA, which, if achieved, would mark consecutive profitable quarters management has framed as a turning point.

Why Investors Are Paying Attention

GrowGeneration remains a bellwether for the broader cannabis-cultivation supply chain, a sector that boomed alongside state-level legalization in 2021 and then collapsed amid oversupply, falling wholesale cannabis prices and a pullback in growers' capital spending. At roughly $85–115 million in market Capitalization depending on the trading day, the stock is a fraction of its 2021-era valuation, when quarterly revenue briefly topped $125 million and shares traded above $30. The August rally, plus a debt-free Balance Sheet and share buybacks, has reignited interest in whether the company's multi-year restructuring, closing underperforming stores, building out proprietary brands, and pivoting toward commercial/B2B distribution, is finally translating into sustainable profitability.

Cannabis-policy developments add another layer of speculative interest. On April 23, 2026, the Department of Justice and DEA moved to place FDA-approved Marijuana Products and state-licensed medical marijuana products into Schedule III of the Controlled Substances Act, and initiated an expedited administrative hearing (beginning June 29, 2026) to consider broader rescheduling of marijuana from Schedule I to Schedule III. On the earnings call, Lampert said GrowGeneration is "well-positioned to support increased Investment activity from our customers" regardless of the ultimate timing. No single company-specific announcement beyond the earnings report and cost-cutting program could be independently verified as explaining the August 12 stock jump; it appears tied to the earnings beat, guidance raise and EBITDA turn rather than any standalone catalyst.

Bull Case

Bulls point to three consecutive quarters of year-over-year revenue growth, a narrowing loss trajectory, and the shift to positive adjusted EBITDA as evidence the multi-year restructuring is inflecting. A debt-free balance sheet with $41 million in cash and marketable securities, an active buyback, and insider purchases suggest management confidence. Rising proprietary-brand penetration (nearing 40%) should support gross margin over time since private-label products typically carry better Economics than resold third-party inventory. Continued federal cannabis-policy movement, even if incremental, could eventually loosen capital constraints on cultivators, GrowGeneration's core customer base.

Bear Case

The retail footprint has shrunk from dozens of stores at its peak to just 19, and further store closures could continue pressuring top-line comparisons even as commercial revenue grows. Gross margin, at 28.5%, remains well below levels needed to support sustained profitability without continued cost discipline, and the company is still net-loss-making on a trailing basis (roughly a $19.6 million trailing-twelve-month net loss, per aggregated market data). The stock's 52-week low of $0.965 sits uncomfortably close to levels that can trigger Nasdaq minimum-bid-price scrutiny for low-priced equities, even though no delisting notice was identified in this research. Broader cannabis and controlled-environment-agriculture end-markets remain structurally oversupplied in several states, and full federal rescheduling, which could reshape competitive dynamics, remains unresolved and subject to further administrative and legal process.

What Could Move the Stock Next?

Key catalysts include third-quarter results (guided at $44–46 million revenue with positive adjusted EBITDA), further updates on the DEA's expedited rescheduling hearing process, additional store-closure or reopening decisions, the pace of proprietary-brand penetration toward the 40% target, continued share-buyback activity, and any signs of Acquisition activity in adjacent agriculture or lawn-and-garden markets, which management said it would consider opportunistically.

A Turnaround Taking Shape After a Brutal Bust

GrowGeneration's August 2026 results complicate a simple "falling knife" story: revenue grew for a third straight quarter, losses narrowed sharply, and adjusted EBITDA turned positive, prompting a sizable one-day stock rally. Yet the bigger picture remains one of a company still working through a multi-year restructuring, a shrunken store base, thin margins, and a stock price that remains a small fraction of its 2021 peak. Federal cannabis-rescheduling developments add a speculative overlay but have not yet delivered a clear, quantifiable benefit to the business. Investors weighing GRWG are essentially betting on whether recent operational improvements, cost cuts, proprietary-brand growth, and a shift toward commercial distribution, can be sustained into consistent profitability, against a backdrop of ongoing sector oversupply and lingering questions about the company's long-term retail footprint.